Ayala Pharmaceuticals Inc (ADXS)

[exel_mm]

Speculative question to the board based on potential

Premise: Suppose one could demonstrate, through data, (prior to any EU or FDA approval) that Advaxis possesses a disruptive platform providing never-before-seen CR numbers across "N" constructs, as well as the flexibility to extend to "N" constructs.

Question: Regardless of the current share price, what would the potential of owning such a platform, outright, be worth?


I will start the bidding: 8 BILLION